<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10799211</article-id>
    <article-id pub-id-type="doi">10.1093/database/baad095</article-id>
    <article-id pub-id-type="publisher-id">baad095</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DAPredict: a database for drug action phenotype prediction</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Meng</surname>
          <given-names>Qingkang</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cai</surname>
          <given-names>Yiyang</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Kun</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xu</surname>
          <given-names>Fei</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huo</surname>
          <given-names>Diwei</given-names>
        </name>
        <aff><institution>The Fourth Affiliated Hospital of Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Hongbo</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Meini</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Denan</given-names>
        </name>
        <!--zhangdenan@ems.hrbmu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2423-8569</contrib-id>
        <name>
          <surname>Chen</surname>
          <given-names>Xiujie</given-names>
        </name>
        <!--chenxiujie@emshrbmu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Tel: +86 139 4509 7808; Email: <email xlink:href="chenxiujie@emshrbmu.edu.cn">chenxiujie@emshrbmu.edu.cn</email> Correspondence may also be addressed to Denan Zhang. Tel: +86 13351887550; Email: <email xlink:href="zhangdenan@ems.hrbmu.edu.cn">zhangdenan@ems.hrbmu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-01-18">
      <day>18</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <volume>2024</volume>
    <elocation-id>baad095</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>9</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>17</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>12</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>04</day>
        <month>12</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>1</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baad095.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>The phenotypes of drug action, including therapeutic actions and adverse drug reactions (ADRs), are important indicators for evaluating the druggability of new drugs and repositioning the approved drugs. Here, we provide a user-friendly database, DAPredict (<ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict</ext-link>), in which our novel original drug action phenotypes prediction algorithm (Yang,J., Zhang,D., Liu,L. <italic toggle="yes">et al.</italic> (2021) Computational drug repositioning based on the relationships between substructure-indication. <italic toggle="yes">Brief. Bioinformatics</italic>, 22, bbaa348) was embedded. Our algorithm integrates characteristics of chemical genomics and pharmacogenomics, breaking through the limitations that traditional drug development process based on phenotype cannot analyze the mechanism of drug action. Predicting phenotypes of drug action based on the local active structures of drugs and proteins can achieve more innovative drug discovery across drug categories and simultaneously evaluate drug efficacy and safety, rather than traditional one-by-one evaluation. DAPredict contains 305 981 predicted relationships between 1748 approved drugs and 454 ADRs, 83 117 predicted relationships between 1478 approved drugs and 178 Anatomical Therapeutic Chemicals (ATC). More importantly, DAPredict provides an online prediction tool, which researchers can use to predict the action phenotypic spectrum of more than 110 000 000 compounds (including about 168 000 natural products) and corresponding proteins to analyze their potential effect mechanisms. DAPredict can also help researchers obtain the phenotype-corresponding active structures for structural optimization of new drug candidates, making it easier to evaluate the druggability of new drug candidates and develop more innovative drugs across drug categories.</p>
      <p><bold>Database URL:</bold>  <ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict/" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict/</ext-link></p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61671191 62072144</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61671191 62072144</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>Introduction</title>
    <p>Drug action phenotypes, also known as drug responses, refer to the sum of all reactions that occur in the organism after medication, including therapeutic effects and adverse drug reactions (ADRs) (<xref rid="R1" ref-type="bibr">1</xref>). The goal of drug research and development (R&amp;D) is to discover new drug candidates (NDCs) that exhibit high treatment effects and minimal adverse reactions. To achieve this goal, understanding the spectrum of therapeutic effects and the most likely serious adverse reactions is crucial for evaluating the druggability of new drug candidates and repositioning the approved drugs. However, the current experimental methods in drug discovery are usually based on disease models, and its process is costly, time-consuming, and has a high risk of failure (<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>), especially the inability to obtain comprehensive action phenotypes, which is a huge challenge for determining the effects on the body of new discovering natural products or new synthesized compounds. While traditional drug phenotype discovery methods are usually referred to the records in ancient medical books or based on folk experience, these can only determine one or several action phenotypes, rather than all action phenotypes, which need to study the disease models of various human organs one by one to determine. Therefore, there is an urgent need to develop calculation methods to break through the above limitations and provide guidance for further experimental research (<xref rid="R4" ref-type="bibr">4</xref>).</p>
    <p>Current researches only choose chemical-genomic features (drug substructure-protein domain) or pharmacogenomic features (drug adverse reaction-protein domain) and does not integrate chemical-genomic features with pharmacogenomic features to identify the relationship between substructure and action phenotype. This is crucial for predicting drug action phenotype profiles solely based on substructure information of new drug candidates, especially, for natural products.</p>
    <p>Most current calculation methods for predicting drug action phenotypes are based on the principle of overall structural similarity of drugs. The basic assumption underlying similarity-based calculations is that structurally similar drugs possess similar functions and, consequently, exhibit similar phenotypic effects. However, these methods have trouble with inconsistencies between structure and function, resulting in what is known as the ‘activity cliff’ phenomenon. This phenomenon implies that the same protein can interact with multiple compounds that are structurally dissimilar or that the same drug can interact with evolutionarily distant proteins (<xref rid="R5" ref-type="bibr">5</xref>). As a result, there is an increasing demand for explaining the interaction mechanisms between drugs and target proteins at a higher resolution, leading to a growing focus on drug development models based on local similarity. The active structural groups of drugs and protein domains serve as the basis for drug-target protein interactions. The same active structural group or domain can exist in different compounds and proteins. Developing drugs based on the interaction between active structural groups of drugs and domains of proteins can effectively showcase the local similarity of drugs and broaden the prediction scope of drug-phenotype relationships, ultimately facilitating innovative drug discovery (<xref rid="R6" ref-type="bibr">6</xref>).</p>
    <p>To speed up solving the above problems, we created a novel original drug action phenotypes prediction algorithm (<xref rid="R7" ref-type="bibr">7</xref>), which integrated chemical-genomic features and pharmacogenomic features and is based on the local active structures of drugs and proteins. Our method not only achieves the goal of predicting the comprehensive action phenotype of drugs but also enables new drug discovery across drug classes because it is based on local active structures, which greatly expands the space for new drug development and facilitates structural optimization. Finally, we provide DAPredict (<ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict</ext-link>), a user-friendly database that embeds our original algorithm for pharmacists to aid in drug discovery (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p>
    <fig position="float" id="F1" fig-type="figure">
      <label>Figure 1.</label>
      <caption>
        <p>The framework of DAPredict. This figure shows the operating principle of DAPredict, which corresponds to the ‘Search’ and ‘Tool’ sections on the web page respectively. (Abbreviation, SUB: Substructure).</p>
      </caption>
      <graphic xlink:href="baad095f1" position="float"/>
      <attrib><bold>Alt text:</bold> A frame diagram showing how the database works.</attrib>
    </fig>
  </sec>
  <sec id="s2">
    <title>Methods</title>
    <sec id="s2-s1">
      <title>Data collection and processing</title>
      <p>Our database mainly contains the following seven relationship pairs, which are drug-ADR, drug-ATC (here, therapeutic effects represented by the third-level ATCs), compound substructure-ADR, compound substructure-ATC, compound substructure-protein domain, protein domain-ADR and protein domain-ATC. These relationship pairs all come from our original prediction algorithms. Specifically, our prediction algorithm constructed the above seven relationship pairs stored in this database based on drug target data and drug therapeutic effect data from the DrugBank database, 881-bit drug substructure data from the PubChem database and protein domain information from the Pfam database.</p>
      <p>For the online prediction tool, we downloaded the compound information in XML format, preprocessed it into compound-substructure relationship pairs and then stored them in the database.</p>
    </sec>
    <sec id="s2-s2">
      <title>Full phenotypic profile</title>
      <p>Predicted drug action phenotype relationships (including drug-ADR and drug-ATC) are stored in the database, and users can directly retrieve the above-mentioned relationship pairs by inputting the interest drug or phenotype to explore the full phenotypic profile of the interest drug.</p>
    </sec>
    <sec id="s2-s3">
      <title>Mechanism of drug action</title>
      <p>Drugs usually play a role in the body by binding to target proteins. The most crucial binding site is the domain of the target protein. Therefore, by analyzing the domain of the target protein, researchers can further explore the mechanism by which the drug exerts its effect or produces adverse reactions.</p>
      <p>Based on the compound-substructure relationships from the PubChem database and the substructure-domain and domain-ADR or ATC relationships from our algorithm, drug-domain-ADR or ATC relationship data were finally constructed and stored in the database. The relationship score is calculated as follows:</p>
      <disp-formula id="UM0001">
        <tex-math notation="LaTeX" id="UM0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{j = 1}^{j = n}Co{r_{sub\,i\, - \,domain\,j}}*Co{r_{domain\,j\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0001"><tex-math notation="LaTeX" id="ILM0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}domain{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given drug and domain <italic toggle="yes">j</italic>, <inline-formula id="ILM0002"><tex-math notation="LaTeX" id="ILM0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{domain{\mathrm{\,}}j{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,or\,}}ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between domain <italic toggle="yes">j</italic> and a given ADR or ATC, where <italic toggle="yes">n</italic> represents the number of intersection domains in the substructure-domain and domain-ADR or ATC relationships.</p>
    </sec>
    <sec id="s2-s4">
      <title>Drug phenotype-associated substructures</title>
      <p>The phenotype-related substructure is the most important information in structural optimization of drug development to eliminate serious adverse drug reactions (SADR). Here, the database provides researchers with valuable drug action phenotype-related substructure information based on compound-substructure relationships from the PubChem database and substructure-ADR or ATC relationships from our algorithm. The relationship score is calculated as follows:</p>
      <disp-formula id="UM0002">
        <tex-math notation="LaTeX" id="UM0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0003"><tex-math notation="LaTeX" id="ILM0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub\,i\, - \,ADR\ \,or\ \,ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given drug and a given ADR or ATC.</p>
    </sec>
    <sec id="s2-s5">
      <title>Online prediction tool</title>
      <p>In addition to the search function of existing data, our database also provides an online prediction tool, which can apply our prediction algorithm to almost all compounds.</p>
      <p>Specifically, for predicting the compound-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0003">
        <tex-math notation="LaTeX" id="UM0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{i = 1}^{i = n}Co{r_{sub\,i\, - \,ADR\,j\,or\,ATC\,j\,}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0004"><tex-math notation="LaTeX" id="ILM0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,}}j{\mathrm{\,}}or{\mathrm{\,}}ATC{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> and ADR j or ATC <italic toggle="yes">j</italic>, where <italic toggle="yes">n</italic> represents the number of substructures of a given compound.</p>
      <p>For predicting compound-domain-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0004">
        <tex-math notation="LaTeX" id="UM0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{j = 1}^{j = n}Co{r_{sub\,i\, - \,domain\,j}}*Co{r_{domain\,j\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0005"><tex-math notation="LaTeX" id="ILM0005-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}domain{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given compound and domain <italic toggle="yes">j</italic>, <inline-formula id="ILM0006"><tex-math notation="LaTeX" id="ILM0006-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{domain{\mathrm{\,}}j{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,or\,}}ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between domain <italic toggle="yes">j</italic> and a given ADR or ATC, where <italic toggle="yes">n</italic> represents the number of intersection domains in the substructure-domain and domain-ADR or ATC relationships. But unlike the search function, these calculations are performed online in real time.</p>
      <p>For predicting compound-substructure-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0005">
        <tex-math notation="LaTeX" id="UM0005-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0007"><tex-math notation="LaTeX" id="ILM0007-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given compound and a given ADR or ATC.</p>
    </sec>
    <sec id="s2-s6">
      <title>Implement</title>
      <p>DAPredict has been developed with Django version 3.2 and Python version 3.7.</p>
    </sec>
  </sec>
  <sec id="s3">
    <title>Results</title>
    <sec id="s3-s1">
      <title>Data in the DAPredict database</title>
      <p>DAPredict contains a total of 1748 approved drugs, 454 ADRs, 178 ATCs and 111 428 061 compounds. Among them, 178 ATCs covered all 14 first-level ATCs, and compounds covered 168 360 natural products. All relationship pairs are counted as shown in <xref rid="T1" ref-type="table">Table 1</xref>; there are 305 981 drug-ADR relationships and 83 117 drug-ATC relationships. A total of 5808 pairs of substructure-ADR relationships, 1748 pairs of substructure-ATC relationships, 33 334 pairs of substructure-domain relationships, 30 874 pairs of domain-ADR relationships and 2788 pairs of domain-ATC relationships came from our prediction algorithm.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1.</label>
        <caption>
          <p>Data in DAPredict. Data: This column represents the type of stored data, including known information obtained from existing databases and relationship pairs predicted by our original algorithm. Source: This column represents the source of stored data. Number: This column represents the number of entries of stored data. Description: This column represents the detailed description of stored data. (Abbreviation, SUB: Substructure)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Data</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Source</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Number</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Description</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Approved drug</td>
              <td align="left" rowspan="1" colspan="1">DrugBank</td>
              <td align="left" rowspan="1" colspan="1">1748</td>
              <td align="left" rowspan="1" colspan="1">Approved drugs for predicting the action phenotype.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ADR</td>
              <td align="left" rowspan="1" colspan="1">SIDER</td>
              <td align="left" rowspan="1" colspan="1">454</td>
              <td align="left" rowspan="1" colspan="1">Adverse reactions to be predicted.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ATC</td>
              <td align="left" rowspan="1" colspan="1">DrugBank</td>
              <td align="left" rowspan="1" colspan="1">178</td>
              <td align="left" rowspan="1" colspan="1">Drug therapy effects to be predicted.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Compound</td>
              <td align="left" rowspan="1" colspan="1">PubChem</td>
              <td align="left" rowspan="1" colspan="1">111 428 061</td>
              <td align="left" rowspan="1" colspan="1">Compounds for predicting the action phenotype online.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">305 981</td>
              <td align="left" rowspan="1" colspan="1">Drug-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">83 117</td>
              <td align="left" rowspan="1" colspan="1">Drug-ATC predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">5808</td>
              <td align="left" rowspan="1" colspan="1">Substructure-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">1748</td>
              <td align="left" rowspan="1" colspan="1">Substructure-ATC predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-Domain</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">33 334</td>
              <td align="left" rowspan="1" colspan="1">Substructure-domain predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">30 874</td>
              <td align="left" rowspan="1" colspan="1">Domain-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">2788</td>
              <td align="left" rowspan="1" colspan="1">Domain-ATC predicted relationships.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="s3-s2">
      <title>Relationship score grade</title>
      <p>To intuitively quantify the degree of relationship scores, all relationship scores are used as the background, and the scores are divided into five levels by quintiles, namely lowest, low, medium, high and highest. The division thresholds for each relationship are shown in <xref rid="T2" ref-type="table">Table 2</xref>.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2.</label>
        <caption>
          <p>Score grade threshold. Relationship: This column shows the names of relationship pairs. Grade: This column represents the five levels of correlation, namely highest, high, medium, low and lowest. Threshold: This column shows the correlation range of each level. (Abbreviation, SUB: Substructure)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Relationship</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Grade</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Threshold</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.000630035,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.0000172,0.000630035]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(1.64E-10,0.0000172]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.56E-21,1.64E-10]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.56E-21]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.00124725,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.00000675,0.00124725]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(7.45E-10,0.00000675]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.28E-22,7.45E-10]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.28E-22]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.1976036,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.00054703,0.1976036]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(3.480196e-16,0.00054703]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(5.73442e-26,3.480196e-16]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,5.73442e-26]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.749394,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.296104,0.749394]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(0.000727606,0.296104]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.13E-13,0.000727606]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.13E-13]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(18.3027,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(10.7562,18.3027]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(6.08470,10.7562]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(2.63413,6.08470]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,2.63413]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(24.3574,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(15.7606,24.3574]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(10.2282,15.7606]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(4.94737,10.2282]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,4.94737]</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Since the prediction of compounds is performed online, it is impossible to obtain the relationship score between all compounds and phenotypes in advance to construct the background, and the approved drugs that have been predicted in advance are representative of all compounds, so the score thresholds of the online prediction were set consistent with the approved drugs.</p>
    </sec>
    <sec id="s3-s3">
      <title>Web interface and visualization</title>
      <p>The web page is divided into five sections, namely home, search, tool, download and help. The home section shows the introduction of DAPredict, and the search section provides users with the direct search function of the pre-predicted full action phenotype spectrum, potential action domain and action phenotype-related substructures of 1748 approved drugs. The tool section provides users with online real-time prediction functions of the full action phenotype spectrum, potential action domain and action phenotype-related substructures of more than 110 000 000 compounds included in the PubChem database. The download section provides users with a wealth of downloadable resources, including the pre-predicted full action phenotype relationship data of 1748 approved drugs, and the relationship data between substructure and ADR, ATC and target protein domain. In addition, DAPredict also includes drug-target relationship data from the DrugBank database and target-domain relationship data from the Pfam database. The help section describes browser compatibility and specific usage tutorial of DAPredict.</p>
      <p>All results in DAPredict are presented in interactive graphs and tables. The forms of interactive graphs include line plots (default) and bar plots (<xref rid="F2" ref-type="fig">Figure 2</xref>). The grade of the relationship score is distinguished by different colors and can be displayed selectively by users in graphs. Due to the limited space on the webpage, we have set a sliding window function for interactive graphs, and users can view the results within the sliding window in more detail by dragging the sliding window. The interactive table provides users with column sorting and a secondary search function by which users can further filter keywords in the search results (<xref rid="F3" ref-type="fig">Figure 3</xref>). Clickable hyperlinks in the table are underlined, and users can easily jump to related sites. Both graphs and tables are available for download in DAPredict.</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>Interactive graph. ① Sliding window: Users can drag the handles at both ends to adjust the size of the sliding window. Drag the sliding window to further explore a specific small range of data. ② Save: Users can save the current graph. ③ Restore: Users can restore the graph to its original form. ④ Bar plot: Users can click this button to switch the default line chart to a bar chart. When the score is very small, it is recommended to view the bar chart. ⑤ Rank: The predicted relevance score is divided into five grades (see the search and tool sections for details), and users can click the label to filter the results by rank attribute. ⑥ Interactive nodes: Users can hover over nodes to view details.</p>
        </caption>
        <graphic xlink:href="baad095f2" position="float"/>
        <attrib><bold>Alt text:</bold> This figure demonstrates the use of interactive graphs in the database.</attrib>
      </fig>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Interactive table. ① Search: search within the form is available to further filter valuable results. ② Format conversion: users can switch the present format of the result form. ③ Column display: users can customize the displayed columns. ④ Export: users can export the result on the current page in CSV or Excel formats (to download all results, please select display number as all.). ⑤ Arrange: users can sort the form in ascending or descending order based on a column. ⑥ Related link: hyperlink is underlined in blue, and users can click to go to the relevant page. ⑦ Display number: the number of results displayed on the current page. ⑧ Page: users can turn pages here.</p>
        </caption>
        <graphic xlink:href="baad095f3" position="float"/>
        <attrib><bold>Alt text:</bold> This figure demonstrates the use of interactive tables in the database.</attrib>
      </fig>
    </sec>
  </sec>
  <sec id="s4">
    <title>Discussion</title>
    <p>We have developed a comprehensive and easy-to-use drug action phenotype search and prediction platform based on our original prediction algorithm, which includes not only the pre-predicted full action phenotype profile of 1748 approved drugs but also the ability to predict more than 110 000 000 known compounds online. It is valuable to reposition approved drugs with reference to the predicted full action phenotype profile, which would save a lot of manpower, resources, finances and time compared to de novo drug development. In addition, the screening of lead compounds is one of the most important steps in the development of new drugs. Predicting and evaluating the action phenotype of known compounds can provide a reference value for the screening of lead compounds, which also includes natural products that are less studied at present. More importantly, DAPredict can also provide researchers with information on the mechanism of action of a drug or compound and substructure information related to the action phenotype, which is of great significance in druggability evaluation and structural optimization in the development of new drugs.</p>
    <p>At present, the number of known compounds is constantly increasing, so our database needs to be constantly updated. In addition, the predicted results may still need to be checked manually. This would be a time-consuming process because of the huge number of compounds. We hope that DAPredict can provide a convenient and valuable data resource for drug developers and pharmacogenomics researchers.</p>
  </sec>
</body>
<back>
  <sec sec-type="data-availability" id="s5">
    <title>Data availability</title>
    <p>All data in DAPredict are stored in the download section, and users can download it on demand.</p>
  </sec>
  <sec id="s6">
    <title>Contribution statement</title>
    <p>Conceptualization, Qingkang Meng and Xiujie Chen; Data curation, Yiyang Cai; Formal analysis, Qingkang Meng, Kun Zhou, Fei Xu and Diwei Huo; Funding acquisition, Xiujie Chen and Denan Zhang; Methodology, Qingkang Meng and Yiyang Cai; Project administration, Qingkang Meng and Xiujie Chen; Software, Kun Zhou, Fei Xu, Diwei Huo, Hongbo Xie, Meini Yu and Denan Zhang; Writing—original draft, Qingkang Meng; Writing—review and editing, Yiyang Cai, Kun Zhou, Fei Xu, Diwei Huo, Hongbo Xie, Meini Yu, Denan Zhang and Xiujie Chen.</p>
  </sec>
  <sec id="s7">
    <title>Funding</title>
    <p>Funding for open access charge: National Human Genome Research Institute (2P41HG02273-07). National Natural Science Foundation of China (Grant Number: 61671191, 62072144).</p>
  </sec>
  <sec sec-type="COI-statement" id="s8">
    <title>Conflict of interest statement</title>
    <p>None declared.</p>
  </sec>
  <sec id="s9">
    <title>Code availability</title>
    <p>No custom code was used. Software tools used for processing are mentioned in the Methods section.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berg</surname><given-names>E.L.</given-names></string-name></person-group> (<year>2021</year>) <article-title>The future of phenotypic drug discovery</article-title>. <source><italic toggle="yes">Cell Chem. Biol.</italic></source>, <volume>28</volume>, <fpage>424</fpage>–<lpage>430</lpage>.<pub-id pub-id-type="pmid">33529582</pub-id>
</mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luo</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2021</year>) <article-title>Biomedical data and computational models for drug repositioning: a comprehensive review</article-title>. <source><italic toggle="yes">Brief. Bioinformatics</italic></source>, <volume>22</volume>, <fpage>1604</fpage>–<lpage>1619</lpage>.<pub-id pub-id-type="pmid">32043521</pub-id>
</mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schcolnik-Cabrera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Juarez-Lopez</surname><given-names>D.</given-names></string-name> and <string-name><surname>Duenas-Gonzalez</surname><given-names>A.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Perspectives on drug repurposing</article-title>. <source><italic toggle="yes">Curr. Med. Chem.</italic></source>, <volume>28</volume>, <fpage>2085</fpage>–<lpage>2099</lpage>.<pub-id pub-id-type="pmid">32867630</pub-id>
</mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brogi</surname><given-names>S.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Computational approaches for drug discovery</article-title>. <source><italic toggle="yes">Molecules</italic></source>, <volume>24</volume>, <page-range>3061</page-range>.</mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2015</year>) <article-title>Predicting drug-target interactions via within-score and between-score</article-title>. <source><italic toggle="yes">BioMed Res. Int.</italic></source>, <volume>2015</volume>, <page-range>350983</page-range>.</mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tabei</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pauwels</surname><given-names>E.</given-names></string-name>, <string-name><surname>Stoven</surname><given-names>V.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2012</year>) <article-title>Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>, <volume>28</volume>, <fpage>i487</fpage>–<lpage>i494</lpage>.<pub-id pub-id-type="pmid">22962471</pub-id>
</mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>L.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2021</year>) <article-title>Computational drug repositioning based on the relationships between substructure-indication</article-title>. <source><italic toggle="yes">Brief. Bioinformatics</italic></source>, <volume>22</volume>, <page-range>bbaa348</page-range>.</mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10799211</article-id>
    <article-id pub-id-type="doi">10.1093/database/baad095</article-id>
    <article-id pub-id-type="publisher-id">baad095</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DAPredict: a database for drug action phenotype prediction</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Meng</surname>
          <given-names>Qingkang</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cai</surname>
          <given-names>Yiyang</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Kun</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xu</surname>
          <given-names>Fei</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huo</surname>
          <given-names>Diwei</given-names>
        </name>
        <aff><institution>The Fourth Affiliated Hospital of Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Hongbo</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Meini</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Denan</given-names>
        </name>
        <!--zhangdenan@ems.hrbmu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2423-8569</contrib-id>
        <name>
          <surname>Chen</surname>
          <given-names>Xiujie</given-names>
        </name>
        <!--chenxiujie@emshrbmu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Tel: +86 139 4509 7808; Email: <email xlink:href="chenxiujie@emshrbmu.edu.cn">chenxiujie@emshrbmu.edu.cn</email> Correspondence may also be addressed to Denan Zhang. Tel: +86 13351887550; Email: <email xlink:href="zhangdenan@ems.hrbmu.edu.cn">zhangdenan@ems.hrbmu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-01-18">
      <day>18</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <volume>2024</volume>
    <elocation-id>baad095</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>9</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>17</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>12</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>04</day>
        <month>12</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>1</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baad095.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>The phenotypes of drug action, including therapeutic actions and adverse drug reactions (ADRs), are important indicators for evaluating the druggability of new drugs and repositioning the approved drugs. Here, we provide a user-friendly database, DAPredict (<ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict</ext-link>), in which our novel original drug action phenotypes prediction algorithm (Yang,J., Zhang,D., Liu,L. <italic toggle="yes">et al.</italic> (2021) Computational drug repositioning based on the relationships between substructure-indication. <italic toggle="yes">Brief. Bioinformatics</italic>, 22, bbaa348) was embedded. Our algorithm integrates characteristics of chemical genomics and pharmacogenomics, breaking through the limitations that traditional drug development process based on phenotype cannot analyze the mechanism of drug action. Predicting phenotypes of drug action based on the local active structures of drugs and proteins can achieve more innovative drug discovery across drug categories and simultaneously evaluate drug efficacy and safety, rather than traditional one-by-one evaluation. DAPredict contains 305 981 predicted relationships between 1748 approved drugs and 454 ADRs, 83 117 predicted relationships between 1478 approved drugs and 178 Anatomical Therapeutic Chemicals (ATC). More importantly, DAPredict provides an online prediction tool, which researchers can use to predict the action phenotypic spectrum of more than 110 000 000 compounds (including about 168 000 natural products) and corresponding proteins to analyze their potential effect mechanisms. DAPredict can also help researchers obtain the phenotype-corresponding active structures for structural optimization of new drug candidates, making it easier to evaluate the druggability of new drug candidates and develop more innovative drugs across drug categories.</p>
      <p><bold>Database URL:</bold>  <ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict/" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict/</ext-link></p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61671191 62072144</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61671191 62072144</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>Introduction</title>
    <p>Drug action phenotypes, also known as drug responses, refer to the sum of all reactions that occur in the organism after medication, including therapeutic effects and adverse drug reactions (ADRs) (<xref rid="R1" ref-type="bibr">1</xref>). The goal of drug research and development (R&amp;D) is to discover new drug candidates (NDCs) that exhibit high treatment effects and minimal adverse reactions. To achieve this goal, understanding the spectrum of therapeutic effects and the most likely serious adverse reactions is crucial for evaluating the druggability of new drug candidates and repositioning the approved drugs. However, the current experimental methods in drug discovery are usually based on disease models, and its process is costly, time-consuming, and has a high risk of failure (<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>), especially the inability to obtain comprehensive action phenotypes, which is a huge challenge for determining the effects on the body of new discovering natural products or new synthesized compounds. While traditional drug phenotype discovery methods are usually referred to the records in ancient medical books or based on folk experience, these can only determine one or several action phenotypes, rather than all action phenotypes, which need to study the disease models of various human organs one by one to determine. Therefore, there is an urgent need to develop calculation methods to break through the above limitations and provide guidance for further experimental research (<xref rid="R4" ref-type="bibr">4</xref>).</p>
    <p>Current researches only choose chemical-genomic features (drug substructure-protein domain) or pharmacogenomic features (drug adverse reaction-protein domain) and does not integrate chemical-genomic features with pharmacogenomic features to identify the relationship between substructure and action phenotype. This is crucial for predicting drug action phenotype profiles solely based on substructure information of new drug candidates, especially, for natural products.</p>
    <p>Most current calculation methods for predicting drug action phenotypes are based on the principle of overall structural similarity of drugs. The basic assumption underlying similarity-based calculations is that structurally similar drugs possess similar functions and, consequently, exhibit similar phenotypic effects. However, these methods have trouble with inconsistencies between structure and function, resulting in what is known as the ‘activity cliff’ phenomenon. This phenomenon implies that the same protein can interact with multiple compounds that are structurally dissimilar or that the same drug can interact with evolutionarily distant proteins (<xref rid="R5" ref-type="bibr">5</xref>). As a result, there is an increasing demand for explaining the interaction mechanisms between drugs and target proteins at a higher resolution, leading to a growing focus on drug development models based on local similarity. The active structural groups of drugs and protein domains serve as the basis for drug-target protein interactions. The same active structural group or domain can exist in different compounds and proteins. Developing drugs based on the interaction between active structural groups of drugs and domains of proteins can effectively showcase the local similarity of drugs and broaden the prediction scope of drug-phenotype relationships, ultimately facilitating innovative drug discovery (<xref rid="R6" ref-type="bibr">6</xref>).</p>
    <p>To speed up solving the above problems, we created a novel original drug action phenotypes prediction algorithm (<xref rid="R7" ref-type="bibr">7</xref>), which integrated chemical-genomic features and pharmacogenomic features and is based on the local active structures of drugs and proteins. Our method not only achieves the goal of predicting the comprehensive action phenotype of drugs but also enables new drug discovery across drug classes because it is based on local active structures, which greatly expands the space for new drug development and facilitates structural optimization. Finally, we provide DAPredict (<ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict</ext-link>), a user-friendly database that embeds our original algorithm for pharmacists to aid in drug discovery (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p>
    <fig position="float" id="F1" fig-type="figure">
      <label>Figure 1.</label>
      <caption>
        <p>The framework of DAPredict. This figure shows the operating principle of DAPredict, which corresponds to the ‘Search’ and ‘Tool’ sections on the web page respectively. (Abbreviation, SUB: Substructure).</p>
      </caption>
      <graphic xlink:href="baad095f1" position="float"/>
      <attrib><bold>Alt text:</bold> A frame diagram showing how the database works.</attrib>
    </fig>
  </sec>
  <sec id="s2">
    <title>Methods</title>
    <sec id="s2-s1">
      <title>Data collection and processing</title>
      <p>Our database mainly contains the following seven relationship pairs, which are drug-ADR, drug-ATC (here, therapeutic effects represented by the third-level ATCs), compound substructure-ADR, compound substructure-ATC, compound substructure-protein domain, protein domain-ADR and protein domain-ATC. These relationship pairs all come from our original prediction algorithms. Specifically, our prediction algorithm constructed the above seven relationship pairs stored in this database based on drug target data and drug therapeutic effect data from the DrugBank database, 881-bit drug substructure data from the PubChem database and protein domain information from the Pfam database.</p>
      <p>For the online prediction tool, we downloaded the compound information in XML format, preprocessed it into compound-substructure relationship pairs and then stored them in the database.</p>
    </sec>
    <sec id="s2-s2">
      <title>Full phenotypic profile</title>
      <p>Predicted drug action phenotype relationships (including drug-ADR and drug-ATC) are stored in the database, and users can directly retrieve the above-mentioned relationship pairs by inputting the interest drug or phenotype to explore the full phenotypic profile of the interest drug.</p>
    </sec>
    <sec id="s2-s3">
      <title>Mechanism of drug action</title>
      <p>Drugs usually play a role in the body by binding to target proteins. The most crucial binding site is the domain of the target protein. Therefore, by analyzing the domain of the target protein, researchers can further explore the mechanism by which the drug exerts its effect or produces adverse reactions.</p>
      <p>Based on the compound-substructure relationships from the PubChem database and the substructure-domain and domain-ADR or ATC relationships from our algorithm, drug-domain-ADR or ATC relationship data were finally constructed and stored in the database. The relationship score is calculated as follows:</p>
      <disp-formula id="UM0001">
        <tex-math notation="LaTeX" id="UM0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{j = 1}^{j = n}Co{r_{sub\,i\, - \,domain\,j}}*Co{r_{domain\,j\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0001"><tex-math notation="LaTeX" id="ILM0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}domain{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given drug and domain <italic toggle="yes">j</italic>, <inline-formula id="ILM0002"><tex-math notation="LaTeX" id="ILM0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{domain{\mathrm{\,}}j{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,or\,}}ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between domain <italic toggle="yes">j</italic> and a given ADR or ATC, where <italic toggle="yes">n</italic> represents the number of intersection domains in the substructure-domain and domain-ADR or ATC relationships.</p>
    </sec>
    <sec id="s2-s4">
      <title>Drug phenotype-associated substructures</title>
      <p>The phenotype-related substructure is the most important information in structural optimization of drug development to eliminate serious adverse drug reactions (SADR). Here, the database provides researchers with valuable drug action phenotype-related substructure information based on compound-substructure relationships from the PubChem database and substructure-ADR or ATC relationships from our algorithm. The relationship score is calculated as follows:</p>
      <disp-formula id="UM0002">
        <tex-math notation="LaTeX" id="UM0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0003"><tex-math notation="LaTeX" id="ILM0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub\,i\, - \,ADR\ \,or\ \,ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given drug and a given ADR or ATC.</p>
    </sec>
    <sec id="s2-s5">
      <title>Online prediction tool</title>
      <p>In addition to the search function of existing data, our database also provides an online prediction tool, which can apply our prediction algorithm to almost all compounds.</p>
      <p>Specifically, for predicting the compound-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0003">
        <tex-math notation="LaTeX" id="UM0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{i = 1}^{i = n}Co{r_{sub\,i\, - \,ADR\,j\,or\,ATC\,j\,}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0004"><tex-math notation="LaTeX" id="ILM0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,}}j{\mathrm{\,}}or{\mathrm{\,}}ATC{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> and ADR j or ATC <italic toggle="yes">j</italic>, where <italic toggle="yes">n</italic> represents the number of substructures of a given compound.</p>
      <p>For predicting compound-domain-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0004">
        <tex-math notation="LaTeX" id="UM0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{j = 1}^{j = n}Co{r_{sub\,i\, - \,domain\,j}}*Co{r_{domain\,j\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0005"><tex-math notation="LaTeX" id="ILM0005-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}domain{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given compound and domain <italic toggle="yes">j</italic>, <inline-formula id="ILM0006"><tex-math notation="LaTeX" id="ILM0006-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{domain{\mathrm{\,}}j{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,or\,}}ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between domain <italic toggle="yes">j</italic> and a given ADR or ATC, where <italic toggle="yes">n</italic> represents the number of intersection domains in the substructure-domain and domain-ADR or ATC relationships. But unlike the search function, these calculations are performed online in real time.</p>
      <p>For predicting compound-substructure-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0005">
        <tex-math notation="LaTeX" id="UM0005-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0007"><tex-math notation="LaTeX" id="ILM0007-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given compound and a given ADR or ATC.</p>
    </sec>
    <sec id="s2-s6">
      <title>Implement</title>
      <p>DAPredict has been developed with Django version 3.2 and Python version 3.7.</p>
    </sec>
  </sec>
  <sec id="s3">
    <title>Results</title>
    <sec id="s3-s1">
      <title>Data in the DAPredict database</title>
      <p>DAPredict contains a total of 1748 approved drugs, 454 ADRs, 178 ATCs and 111 428 061 compounds. Among them, 178 ATCs covered all 14 first-level ATCs, and compounds covered 168 360 natural products. All relationship pairs are counted as shown in <xref rid="T1" ref-type="table">Table 1</xref>; there are 305 981 drug-ADR relationships and 83 117 drug-ATC relationships. A total of 5808 pairs of substructure-ADR relationships, 1748 pairs of substructure-ATC relationships, 33 334 pairs of substructure-domain relationships, 30 874 pairs of domain-ADR relationships and 2788 pairs of domain-ATC relationships came from our prediction algorithm.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1.</label>
        <caption>
          <p>Data in DAPredict. Data: This column represents the type of stored data, including known information obtained from existing databases and relationship pairs predicted by our original algorithm. Source: This column represents the source of stored data. Number: This column represents the number of entries of stored data. Description: This column represents the detailed description of stored data. (Abbreviation, SUB: Substructure)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Data</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Source</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Number</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Description</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Approved drug</td>
              <td align="left" rowspan="1" colspan="1">DrugBank</td>
              <td align="left" rowspan="1" colspan="1">1748</td>
              <td align="left" rowspan="1" colspan="1">Approved drugs for predicting the action phenotype.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ADR</td>
              <td align="left" rowspan="1" colspan="1">SIDER</td>
              <td align="left" rowspan="1" colspan="1">454</td>
              <td align="left" rowspan="1" colspan="1">Adverse reactions to be predicted.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ATC</td>
              <td align="left" rowspan="1" colspan="1">DrugBank</td>
              <td align="left" rowspan="1" colspan="1">178</td>
              <td align="left" rowspan="1" colspan="1">Drug therapy effects to be predicted.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Compound</td>
              <td align="left" rowspan="1" colspan="1">PubChem</td>
              <td align="left" rowspan="1" colspan="1">111 428 061</td>
              <td align="left" rowspan="1" colspan="1">Compounds for predicting the action phenotype online.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">305 981</td>
              <td align="left" rowspan="1" colspan="1">Drug-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">83 117</td>
              <td align="left" rowspan="1" colspan="1">Drug-ATC predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">5808</td>
              <td align="left" rowspan="1" colspan="1">Substructure-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">1748</td>
              <td align="left" rowspan="1" colspan="1">Substructure-ATC predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-Domain</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">33 334</td>
              <td align="left" rowspan="1" colspan="1">Substructure-domain predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">30 874</td>
              <td align="left" rowspan="1" colspan="1">Domain-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">2788</td>
              <td align="left" rowspan="1" colspan="1">Domain-ATC predicted relationships.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="s3-s2">
      <title>Relationship score grade</title>
      <p>To intuitively quantify the degree of relationship scores, all relationship scores are used as the background, and the scores are divided into five levels by quintiles, namely lowest, low, medium, high and highest. The division thresholds for each relationship are shown in <xref rid="T2" ref-type="table">Table 2</xref>.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2.</label>
        <caption>
          <p>Score grade threshold. Relationship: This column shows the names of relationship pairs. Grade: This column represents the five levels of correlation, namely highest, high, medium, low and lowest. Threshold: This column shows the correlation range of each level. (Abbreviation, SUB: Substructure)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Relationship</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Grade</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Threshold</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.000630035,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.0000172,0.000630035]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(1.64E-10,0.0000172]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.56E-21,1.64E-10]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.56E-21]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.00124725,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.00000675,0.00124725]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(7.45E-10,0.00000675]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.28E-22,7.45E-10]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.28E-22]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.1976036,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.00054703,0.1976036]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(3.480196e-16,0.00054703]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(5.73442e-26,3.480196e-16]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,5.73442e-26]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.749394,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.296104,0.749394]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(0.000727606,0.296104]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.13E-13,0.000727606]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.13E-13]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(18.3027,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(10.7562,18.3027]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(6.08470,10.7562]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(2.63413,6.08470]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,2.63413]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(24.3574,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(15.7606,24.3574]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(10.2282,15.7606]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(4.94737,10.2282]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,4.94737]</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Since the prediction of compounds is performed online, it is impossible to obtain the relationship score between all compounds and phenotypes in advance to construct the background, and the approved drugs that have been predicted in advance are representative of all compounds, so the score thresholds of the online prediction were set consistent with the approved drugs.</p>
    </sec>
    <sec id="s3-s3">
      <title>Web interface and visualization</title>
      <p>The web page is divided into five sections, namely home, search, tool, download and help. The home section shows the introduction of DAPredict, and the search section provides users with the direct search function of the pre-predicted full action phenotype spectrum, potential action domain and action phenotype-related substructures of 1748 approved drugs. The tool section provides users with online real-time prediction functions of the full action phenotype spectrum, potential action domain and action phenotype-related substructures of more than 110 000 000 compounds included in the PubChem database. The download section provides users with a wealth of downloadable resources, including the pre-predicted full action phenotype relationship data of 1748 approved drugs, and the relationship data between substructure and ADR, ATC and target protein domain. In addition, DAPredict also includes drug-target relationship data from the DrugBank database and target-domain relationship data from the Pfam database. The help section describes browser compatibility and specific usage tutorial of DAPredict.</p>
      <p>All results in DAPredict are presented in interactive graphs and tables. The forms of interactive graphs include line plots (default) and bar plots (<xref rid="F2" ref-type="fig">Figure 2</xref>). The grade of the relationship score is distinguished by different colors and can be displayed selectively by users in graphs. Due to the limited space on the webpage, we have set a sliding window function for interactive graphs, and users can view the results within the sliding window in more detail by dragging the sliding window. The interactive table provides users with column sorting and a secondary search function by which users can further filter keywords in the search results (<xref rid="F3" ref-type="fig">Figure 3</xref>). Clickable hyperlinks in the table are underlined, and users can easily jump to related sites. Both graphs and tables are available for download in DAPredict.</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>Interactive graph. ① Sliding window: Users can drag the handles at both ends to adjust the size of the sliding window. Drag the sliding window to further explore a specific small range of data. ② Save: Users can save the current graph. ③ Restore: Users can restore the graph to its original form. ④ Bar plot: Users can click this button to switch the default line chart to a bar chart. When the score is very small, it is recommended to view the bar chart. ⑤ Rank: The predicted relevance score is divided into five grades (see the search and tool sections for details), and users can click the label to filter the results by rank attribute. ⑥ Interactive nodes: Users can hover over nodes to view details.</p>
        </caption>
        <graphic xlink:href="baad095f2" position="float"/>
        <attrib><bold>Alt text:</bold> This figure demonstrates the use of interactive graphs in the database.</attrib>
      </fig>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Interactive table. ① Search: search within the form is available to further filter valuable results. ② Format conversion: users can switch the present format of the result form. ③ Column display: users can customize the displayed columns. ④ Export: users can export the result on the current page in CSV or Excel formats (to download all results, please select display number as all.). ⑤ Arrange: users can sort the form in ascending or descending order based on a column. ⑥ Related link: hyperlink is underlined in blue, and users can click to go to the relevant page. ⑦ Display number: the number of results displayed on the current page. ⑧ Page: users can turn pages here.</p>
        </caption>
        <graphic xlink:href="baad095f3" position="float"/>
        <attrib><bold>Alt text:</bold> This figure demonstrates the use of interactive tables in the database.</attrib>
      </fig>
    </sec>
  </sec>
  <sec id="s4">
    <title>Discussion</title>
    <p>We have developed a comprehensive and easy-to-use drug action phenotype search and prediction platform based on our original prediction algorithm, which includes not only the pre-predicted full action phenotype profile of 1748 approved drugs but also the ability to predict more than 110 000 000 known compounds online. It is valuable to reposition approved drugs with reference to the predicted full action phenotype profile, which would save a lot of manpower, resources, finances and time compared to de novo drug development. In addition, the screening of lead compounds is one of the most important steps in the development of new drugs. Predicting and evaluating the action phenotype of known compounds can provide a reference value for the screening of lead compounds, which also includes natural products that are less studied at present. More importantly, DAPredict can also provide researchers with information on the mechanism of action of a drug or compound and substructure information related to the action phenotype, which is of great significance in druggability evaluation and structural optimization in the development of new drugs.</p>
    <p>At present, the number of known compounds is constantly increasing, so our database needs to be constantly updated. In addition, the predicted results may still need to be checked manually. This would be a time-consuming process because of the huge number of compounds. We hope that DAPredict can provide a convenient and valuable data resource for drug developers and pharmacogenomics researchers.</p>
  </sec>
</body>
<back>
  <sec sec-type="data-availability" id="s5">
    <title>Data availability</title>
    <p>All data in DAPredict are stored in the download section, and users can download it on demand.</p>
  </sec>
  <sec id="s6">
    <title>Contribution statement</title>
    <p>Conceptualization, Qingkang Meng and Xiujie Chen; Data curation, Yiyang Cai; Formal analysis, Qingkang Meng, Kun Zhou, Fei Xu and Diwei Huo; Funding acquisition, Xiujie Chen and Denan Zhang; Methodology, Qingkang Meng and Yiyang Cai; Project administration, Qingkang Meng and Xiujie Chen; Software, Kun Zhou, Fei Xu, Diwei Huo, Hongbo Xie, Meini Yu and Denan Zhang; Writing—original draft, Qingkang Meng; Writing—review and editing, Yiyang Cai, Kun Zhou, Fei Xu, Diwei Huo, Hongbo Xie, Meini Yu, Denan Zhang and Xiujie Chen.</p>
  </sec>
  <sec id="s7">
    <title>Funding</title>
    <p>Funding for open access charge: National Human Genome Research Institute (2P41HG02273-07). National Natural Science Foundation of China (Grant Number: 61671191, 62072144).</p>
  </sec>
  <sec sec-type="COI-statement" id="s8">
    <title>Conflict of interest statement</title>
    <p>None declared.</p>
  </sec>
  <sec id="s9">
    <title>Code availability</title>
    <p>No custom code was used. Software tools used for processing are mentioned in the Methods section.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berg</surname><given-names>E.L.</given-names></string-name></person-group> (<year>2021</year>) <article-title>The future of phenotypic drug discovery</article-title>. <source><italic toggle="yes">Cell Chem. Biol.</italic></source>, <volume>28</volume>, <fpage>424</fpage>–<lpage>430</lpage>.<pub-id pub-id-type="pmid">33529582</pub-id>
</mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luo</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2021</year>) <article-title>Biomedical data and computational models for drug repositioning: a comprehensive review</article-title>. <source><italic toggle="yes">Brief. Bioinformatics</italic></source>, <volume>22</volume>, <fpage>1604</fpage>–<lpage>1619</lpage>.<pub-id pub-id-type="pmid">32043521</pub-id>
</mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schcolnik-Cabrera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Juarez-Lopez</surname><given-names>D.</given-names></string-name> and <string-name><surname>Duenas-Gonzalez</surname><given-names>A.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Perspectives on drug repurposing</article-title>. <source><italic toggle="yes">Curr. Med. Chem.</italic></source>, <volume>28</volume>, <fpage>2085</fpage>–<lpage>2099</lpage>.<pub-id pub-id-type="pmid">32867630</pub-id>
</mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brogi</surname><given-names>S.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Computational approaches for drug discovery</article-title>. <source><italic toggle="yes">Molecules</italic></source>, <volume>24</volume>, <page-range>3061</page-range>.</mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2015</year>) <article-title>Predicting drug-target interactions via within-score and between-score</article-title>. <source><italic toggle="yes">BioMed Res. Int.</italic></source>, <volume>2015</volume>, <page-range>350983</page-range>.</mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tabei</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pauwels</surname><given-names>E.</given-names></string-name>, <string-name><surname>Stoven</surname><given-names>V.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2012</year>) <article-title>Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>, <volume>28</volume>, <fpage>i487</fpage>–<lpage>i494</lpage>.<pub-id pub-id-type="pmid">22962471</pub-id>
</mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>L.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2021</year>) <article-title>Computational drug repositioning based on the relationships between substructure-indication</article-title>. <source><italic toggle="yes">Brief. Bioinformatics</italic></source>, <volume>22</volume>, <page-range>bbaa348</page-range>.</mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10799211</article-id>
    <article-id pub-id-type="doi">10.1093/database/baad095</article-id>
    <article-id pub-id-type="publisher-id">baad095</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DAPredict: a database for drug action phenotype prediction</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Meng</surname>
          <given-names>Qingkang</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cai</surname>
          <given-names>Yiyang</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Kun</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xu</surname>
          <given-names>Fei</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huo</surname>
          <given-names>Diwei</given-names>
        </name>
        <aff><institution>The Fourth Affiliated Hospital of Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Hongbo</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Meini</given-names>
        </name>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Denan</given-names>
        </name>
        <!--zhangdenan@ems.hrbmu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2423-8569</contrib-id>
        <name>
          <surname>Chen</surname>
          <given-names>Xiujie</given-names>
        </name>
        <!--chenxiujie@emshrbmu.edu.cn-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Corresponding author: Tel: +86 139 4509 7808; Email: <email xlink:href="chenxiujie@emshrbmu.edu.cn">chenxiujie@emshrbmu.edu.cn</email> Correspondence may also be addressed to Denan Zhang. Tel: +86 13351887550; Email: <email xlink:href="zhangdenan@ems.hrbmu.edu.cn">zhangdenan@ems.hrbmu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-01-18">
      <day>18</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <volume>2024</volume>
    <elocation-id>baad095</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>9</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>17</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>12</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>04</day>
        <month>12</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>1</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baad095.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>The phenotypes of drug action, including therapeutic actions and adverse drug reactions (ADRs), are important indicators for evaluating the druggability of new drugs and repositioning the approved drugs. Here, we provide a user-friendly database, DAPredict (<ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict</ext-link>), in which our novel original drug action phenotypes prediction algorithm (Yang,J., Zhang,D., Liu,L. <italic toggle="yes">et al.</italic> (2021) Computational drug repositioning based on the relationships between substructure-indication. <italic toggle="yes">Brief. Bioinformatics</italic>, 22, bbaa348) was embedded. Our algorithm integrates characteristics of chemical genomics and pharmacogenomics, breaking through the limitations that traditional drug development process based on phenotype cannot analyze the mechanism of drug action. Predicting phenotypes of drug action based on the local active structures of drugs and proteins can achieve more innovative drug discovery across drug categories and simultaneously evaluate drug efficacy and safety, rather than traditional one-by-one evaluation. DAPredict contains 305 981 predicted relationships between 1748 approved drugs and 454 ADRs, 83 117 predicted relationships between 1478 approved drugs and 178 Anatomical Therapeutic Chemicals (ATC). More importantly, DAPredict provides an online prediction tool, which researchers can use to predict the action phenotypic spectrum of more than 110 000 000 compounds (including about 168 000 natural products) and corresponding proteins to analyze their potential effect mechanisms. DAPredict can also help researchers obtain the phenotype-corresponding active structures for structural optimization of new drug candidates, making it easier to evaluate the druggability of new drug candidates and develop more innovative drugs across drug categories.</p>
      <p><bold>Database URL:</bold>  <ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict/" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict/</ext-link></p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61671191 62072144</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61671191 62072144</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>Introduction</title>
    <p>Drug action phenotypes, also known as drug responses, refer to the sum of all reactions that occur in the organism after medication, including therapeutic effects and adverse drug reactions (ADRs) (<xref rid="R1" ref-type="bibr">1</xref>). The goal of drug research and development (R&amp;D) is to discover new drug candidates (NDCs) that exhibit high treatment effects and minimal adverse reactions. To achieve this goal, understanding the spectrum of therapeutic effects and the most likely serious adverse reactions is crucial for evaluating the druggability of new drug candidates and repositioning the approved drugs. However, the current experimental methods in drug discovery are usually based on disease models, and its process is costly, time-consuming, and has a high risk of failure (<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>), especially the inability to obtain comprehensive action phenotypes, which is a huge challenge for determining the effects on the body of new discovering natural products or new synthesized compounds. While traditional drug phenotype discovery methods are usually referred to the records in ancient medical books or based on folk experience, these can only determine one or several action phenotypes, rather than all action phenotypes, which need to study the disease models of various human organs one by one to determine. Therefore, there is an urgent need to develop calculation methods to break through the above limitations and provide guidance for further experimental research (<xref rid="R4" ref-type="bibr">4</xref>).</p>
    <p>Current researches only choose chemical-genomic features (drug substructure-protein domain) or pharmacogenomic features (drug adverse reaction-protein domain) and does not integrate chemical-genomic features with pharmacogenomic features to identify the relationship between substructure and action phenotype. This is crucial for predicting drug action phenotype profiles solely based on substructure information of new drug candidates, especially, for natural products.</p>
    <p>Most current calculation methods for predicting drug action phenotypes are based on the principle of overall structural similarity of drugs. The basic assumption underlying similarity-based calculations is that structurally similar drugs possess similar functions and, consequently, exhibit similar phenotypic effects. However, these methods have trouble with inconsistencies between structure and function, resulting in what is known as the ‘activity cliff’ phenomenon. This phenomenon implies that the same protein can interact with multiple compounds that are structurally dissimilar or that the same drug can interact with evolutionarily distant proteins (<xref rid="R5" ref-type="bibr">5</xref>). As a result, there is an increasing demand for explaining the interaction mechanisms between drugs and target proteins at a higher resolution, leading to a growing focus on drug development models based on local similarity. The active structural groups of drugs and protein domains serve as the basis for drug-target protein interactions. The same active structural group or domain can exist in different compounds and proteins. Developing drugs based on the interaction between active structural groups of drugs and domains of proteins can effectively showcase the local similarity of drugs and broaden the prediction scope of drug-phenotype relationships, ultimately facilitating innovative drug discovery (<xref rid="R6" ref-type="bibr">6</xref>).</p>
    <p>To speed up solving the above problems, we created a novel original drug action phenotypes prediction algorithm (<xref rid="R7" ref-type="bibr">7</xref>), which integrated chemical-genomic features and pharmacogenomic features and is based on the local active structures of drugs and proteins. Our method not only achieves the goal of predicting the comprehensive action phenotype of drugs but also enables new drug discovery across drug classes because it is based on local active structures, which greatly expands the space for new drug development and facilitates structural optimization. Finally, we provide DAPredict (<ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/DAPredict" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/DAPredict</ext-link>), a user-friendly database that embeds our original algorithm for pharmacists to aid in drug discovery (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p>
    <fig position="float" id="F1" fig-type="figure">
      <label>Figure 1.</label>
      <caption>
        <p>The framework of DAPredict. This figure shows the operating principle of DAPredict, which corresponds to the ‘Search’ and ‘Tool’ sections on the web page respectively. (Abbreviation, SUB: Substructure).</p>
      </caption>
      <graphic xlink:href="baad095f1" position="float"/>
      <attrib><bold>Alt text:</bold> A frame diagram showing how the database works.</attrib>
    </fig>
  </sec>
  <sec id="s2">
    <title>Methods</title>
    <sec id="s2-s1">
      <title>Data collection and processing</title>
      <p>Our database mainly contains the following seven relationship pairs, which are drug-ADR, drug-ATC (here, therapeutic effects represented by the third-level ATCs), compound substructure-ADR, compound substructure-ATC, compound substructure-protein domain, protein domain-ADR and protein domain-ATC. These relationship pairs all come from our original prediction algorithms. Specifically, our prediction algorithm constructed the above seven relationship pairs stored in this database based on drug target data and drug therapeutic effect data from the DrugBank database, 881-bit drug substructure data from the PubChem database and protein domain information from the Pfam database.</p>
      <p>For the online prediction tool, we downloaded the compound information in XML format, preprocessed it into compound-substructure relationship pairs and then stored them in the database.</p>
    </sec>
    <sec id="s2-s2">
      <title>Full phenotypic profile</title>
      <p>Predicted drug action phenotype relationships (including drug-ADR and drug-ATC) are stored in the database, and users can directly retrieve the above-mentioned relationship pairs by inputting the interest drug or phenotype to explore the full phenotypic profile of the interest drug.</p>
    </sec>
    <sec id="s2-s3">
      <title>Mechanism of drug action</title>
      <p>Drugs usually play a role in the body by binding to target proteins. The most crucial binding site is the domain of the target protein. Therefore, by analyzing the domain of the target protein, researchers can further explore the mechanism by which the drug exerts its effect or produces adverse reactions.</p>
      <p>Based on the compound-substructure relationships from the PubChem database and the substructure-domain and domain-ADR or ATC relationships from our algorithm, drug-domain-ADR or ATC relationship data were finally constructed and stored in the database. The relationship score is calculated as follows:</p>
      <disp-formula id="UM0001">
        <tex-math notation="LaTeX" id="UM0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{j = 1}^{j = n}Co{r_{sub\,i\, - \,domain\,j}}*Co{r_{domain\,j\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0001"><tex-math notation="LaTeX" id="ILM0001-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}domain{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given drug and domain <italic toggle="yes">j</italic>, <inline-formula id="ILM0002"><tex-math notation="LaTeX" id="ILM0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{domain{\mathrm{\,}}j{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,or\,}}ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between domain <italic toggle="yes">j</italic> and a given ADR or ATC, where <italic toggle="yes">n</italic> represents the number of intersection domains in the substructure-domain and domain-ADR or ATC relationships.</p>
    </sec>
    <sec id="s2-s4">
      <title>Drug phenotype-associated substructures</title>
      <p>The phenotype-related substructure is the most important information in structural optimization of drug development to eliminate serious adverse drug reactions (SADR). Here, the database provides researchers with valuable drug action phenotype-related substructure information based on compound-substructure relationships from the PubChem database and substructure-ADR or ATC relationships from our algorithm. The relationship score is calculated as follows:</p>
      <disp-formula id="UM0002">
        <tex-math notation="LaTeX" id="UM0002-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0003"><tex-math notation="LaTeX" id="ILM0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub\,i\, - \,ADR\ \,or\ \,ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given drug and a given ADR or ATC.</p>
    </sec>
    <sec id="s2-s5">
      <title>Online prediction tool</title>
      <p>In addition to the search function of existing data, our database also provides an online prediction tool, which can apply our prediction algorithm to almost all compounds.</p>
      <p>Specifically, for predicting the compound-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0003">
        <tex-math notation="LaTeX" id="UM0003-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{i = 1}^{i = n}Co{r_{sub\,i\, - \,ADR\,j\,or\,ATC\,j\,}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0004"><tex-math notation="LaTeX" id="ILM0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,}}j{\mathrm{\,}}or{\mathrm{\,}}ATC{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> and ADR j or ATC <italic toggle="yes">j</italic>, where <italic toggle="yes">n</italic> represents the number of substructures of a given compound.</p>
      <p>For predicting compound-domain-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0004">
        <tex-math notation="LaTeX" id="UM0004-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = {{\Sigma }}_{j = 1}^{j = n}Co{r_{sub\,i\, - \,domain\,j}}*Co{r_{domain\,j\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0005"><tex-math notation="LaTeX" id="ILM0005-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub{\mathrm{\,}}i{\mathrm{\,}} - {\mathrm{\,}}domain{\mathrm{\,}}j}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given compound and domain <italic toggle="yes">j</italic>, <inline-formula id="ILM0006"><tex-math notation="LaTeX" id="ILM0006-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{domain{\mathrm{\,}}j{\mathrm{\,}} - {\mathrm{\,}}ADR{\mathrm{\,or\,}}ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between domain <italic toggle="yes">j</italic> and a given ADR or ATC, where <italic toggle="yes">n</italic> represents the number of intersection domains in the substructure-domain and domain-ADR or ATC relationships. But unlike the search function, these calculations are performed online in real time.</p>
      <p>For predicting compound-substructure-ADR or ATC relationships, the calculation formula is as follows:</p>
      <disp-formula id="UM0005">
        <tex-math notation="LaTeX" id="UM0005-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$Score = Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$$\end{document}</tex-math>
      </disp-formula>
      <p><inline-formula id="ILM0007"><tex-math notation="LaTeX" id="ILM0007-Latex">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$Co{r_{sub\,i\, - \,ADR\,or\,ATC}}$\end{document}</tex-math></inline-formula> represents the relationship score between substructure <italic toggle="yes">i</italic> of a given compound and a given ADR or ATC.</p>
    </sec>
    <sec id="s2-s6">
      <title>Implement</title>
      <p>DAPredict has been developed with Django version 3.2 and Python version 3.7.</p>
    </sec>
  </sec>
  <sec id="s3">
    <title>Results</title>
    <sec id="s3-s1">
      <title>Data in the DAPredict database</title>
      <p>DAPredict contains a total of 1748 approved drugs, 454 ADRs, 178 ATCs and 111 428 061 compounds. Among them, 178 ATCs covered all 14 first-level ATCs, and compounds covered 168 360 natural products. All relationship pairs are counted as shown in <xref rid="T1" ref-type="table">Table 1</xref>; there are 305 981 drug-ADR relationships and 83 117 drug-ATC relationships. A total of 5808 pairs of substructure-ADR relationships, 1748 pairs of substructure-ATC relationships, 33 334 pairs of substructure-domain relationships, 30 874 pairs of domain-ADR relationships and 2788 pairs of domain-ATC relationships came from our prediction algorithm.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1.</label>
        <caption>
          <p>Data in DAPredict. Data: This column represents the type of stored data, including known information obtained from existing databases and relationship pairs predicted by our original algorithm. Source: This column represents the source of stored data. Number: This column represents the number of entries of stored data. Description: This column represents the detailed description of stored data. (Abbreviation, SUB: Substructure)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Data</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Source</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Number</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Description</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Approved drug</td>
              <td align="left" rowspan="1" colspan="1">DrugBank</td>
              <td align="left" rowspan="1" colspan="1">1748</td>
              <td align="left" rowspan="1" colspan="1">Approved drugs for predicting the action phenotype.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ADR</td>
              <td align="left" rowspan="1" colspan="1">SIDER</td>
              <td align="left" rowspan="1" colspan="1">454</td>
              <td align="left" rowspan="1" colspan="1">Adverse reactions to be predicted.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ATC</td>
              <td align="left" rowspan="1" colspan="1">DrugBank</td>
              <td align="left" rowspan="1" colspan="1">178</td>
              <td align="left" rowspan="1" colspan="1">Drug therapy effects to be predicted.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Compound</td>
              <td align="left" rowspan="1" colspan="1">PubChem</td>
              <td align="left" rowspan="1" colspan="1">111 428 061</td>
              <td align="left" rowspan="1" colspan="1">Compounds for predicting the action phenotype online.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">305 981</td>
              <td align="left" rowspan="1" colspan="1">Drug-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">83 117</td>
              <td align="left" rowspan="1" colspan="1">Drug-ATC predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">5808</td>
              <td align="left" rowspan="1" colspan="1">Substructure-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">1748</td>
              <td align="left" rowspan="1" colspan="1">Substructure-ATC predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SUB-Domain</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">33 334</td>
              <td align="left" rowspan="1" colspan="1">Substructure-domain predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">30 874</td>
              <td align="left" rowspan="1" colspan="1">Domain-ADR predicted relationships.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Original algorithm</td>
              <td align="left" rowspan="1" colspan="1">2788</td>
              <td align="left" rowspan="1" colspan="1">Domain-ATC predicted relationships.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="s3-s2">
      <title>Relationship score grade</title>
      <p>To intuitively quantify the degree of relationship scores, all relationship scores are used as the background, and the scores are divided into five levels by quintiles, namely lowest, low, medium, high and highest. The division thresholds for each relationship are shown in <xref rid="T2" ref-type="table">Table 2</xref>.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2.</label>
        <caption>
          <p>Score grade threshold. Relationship: This column shows the names of relationship pairs. Grade: This column represents the five levels of correlation, namely highest, high, medium, low and lowest. Threshold: This column shows the correlation range of each level. (Abbreviation, SUB: Substructure)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Relationship</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Grade</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Threshold</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.000630035,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.0000172,0.000630035]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(1.64E-10,0.0000172]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.56E-21,1.64E-10]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.56E-21]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.00124725,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.00000675,0.00124725]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(7.45E-10,0.00000675]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.28E-22,7.45E-10]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.28E-22]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.1976036,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.00054703,0.1976036]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(3.480196e-16,0.00054703]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(5.73442e-26,3.480196e-16]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,5.73442e-26]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(0.749394,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(0.296104,0.749394]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(0.000727606,0.296104]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(3.13E-13,0.000727606]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-SUB-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,3.13E-13]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(18.3027,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(10.7562,18.3027]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(6.08470,10.7562]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(2.63413,6.08470]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ADR</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,2.63413]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Highest</td>
              <td align="left" rowspan="1" colspan="1">(24.3574,+∞)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">High</td>
              <td align="left" rowspan="1" colspan="1">(15.7606,24.3574]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Medium</td>
              <td align="left" rowspan="1" colspan="1">(10.2282,15.7606]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Low</td>
              <td align="left" rowspan="1" colspan="1">(4.94737,10.2282]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Drug-Domain-ATC</td>
              <td align="left" rowspan="1" colspan="1">Lowest</td>
              <td align="left" rowspan="1" colspan="1">(0,4.94737]</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Since the prediction of compounds is performed online, it is impossible to obtain the relationship score between all compounds and phenotypes in advance to construct the background, and the approved drugs that have been predicted in advance are representative of all compounds, so the score thresholds of the online prediction were set consistent with the approved drugs.</p>
    </sec>
    <sec id="s3-s3">
      <title>Web interface and visualization</title>
      <p>The web page is divided into five sections, namely home, search, tool, download and help. The home section shows the introduction of DAPredict, and the search section provides users with the direct search function of the pre-predicted full action phenotype spectrum, potential action domain and action phenotype-related substructures of 1748 approved drugs. The tool section provides users with online real-time prediction functions of the full action phenotype spectrum, potential action domain and action phenotype-related substructures of more than 110 000 000 compounds included in the PubChem database. The download section provides users with a wealth of downloadable resources, including the pre-predicted full action phenotype relationship data of 1748 approved drugs, and the relationship data between substructure and ADR, ATC and target protein domain. In addition, DAPredict also includes drug-target relationship data from the DrugBank database and target-domain relationship data from the Pfam database. The help section describes browser compatibility and specific usage tutorial of DAPredict.</p>
      <p>All results in DAPredict are presented in interactive graphs and tables. The forms of interactive graphs include line plots (default) and bar plots (<xref rid="F2" ref-type="fig">Figure 2</xref>). The grade of the relationship score is distinguished by different colors and can be displayed selectively by users in graphs. Due to the limited space on the webpage, we have set a sliding window function for interactive graphs, and users can view the results within the sliding window in more detail by dragging the sliding window. The interactive table provides users with column sorting and a secondary search function by which users can further filter keywords in the search results (<xref rid="F3" ref-type="fig">Figure 3</xref>). Clickable hyperlinks in the table are underlined, and users can easily jump to related sites. Both graphs and tables are available for download in DAPredict.</p>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>Interactive graph. ① Sliding window: Users can drag the handles at both ends to adjust the size of the sliding window. Drag the sliding window to further explore a specific small range of data. ② Save: Users can save the current graph. ③ Restore: Users can restore the graph to its original form. ④ Bar plot: Users can click this button to switch the default line chart to a bar chart. When the score is very small, it is recommended to view the bar chart. ⑤ Rank: The predicted relevance score is divided into five grades (see the search and tool sections for details), and users can click the label to filter the results by rank attribute. ⑥ Interactive nodes: Users can hover over nodes to view details.</p>
        </caption>
        <graphic xlink:href="baad095f2" position="float"/>
        <attrib><bold>Alt text:</bold> This figure demonstrates the use of interactive graphs in the database.</attrib>
      </fig>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Interactive table. ① Search: search within the form is available to further filter valuable results. ② Format conversion: users can switch the present format of the result form. ③ Column display: users can customize the displayed columns. ④ Export: users can export the result on the current page in CSV or Excel formats (to download all results, please select display number as all.). ⑤ Arrange: users can sort the form in ascending or descending order based on a column. ⑥ Related link: hyperlink is underlined in blue, and users can click to go to the relevant page. ⑦ Display number: the number of results displayed on the current page. ⑧ Page: users can turn pages here.</p>
        </caption>
        <graphic xlink:href="baad095f3" position="float"/>
        <attrib><bold>Alt text:</bold> This figure demonstrates the use of interactive tables in the database.</attrib>
      </fig>
    </sec>
  </sec>
  <sec id="s4">
    <title>Discussion</title>
    <p>We have developed a comprehensive and easy-to-use drug action phenotype search and prediction platform based on our original prediction algorithm, which includes not only the pre-predicted full action phenotype profile of 1748 approved drugs but also the ability to predict more than 110 000 000 known compounds online. It is valuable to reposition approved drugs with reference to the predicted full action phenotype profile, which would save a lot of manpower, resources, finances and time compared to de novo drug development. In addition, the screening of lead compounds is one of the most important steps in the development of new drugs. Predicting and evaluating the action phenotype of known compounds can provide a reference value for the screening of lead compounds, which also includes natural products that are less studied at present. More importantly, DAPredict can also provide researchers with information on the mechanism of action of a drug or compound and substructure information related to the action phenotype, which is of great significance in druggability evaluation and structural optimization in the development of new drugs.</p>
    <p>At present, the number of known compounds is constantly increasing, so our database needs to be constantly updated. In addition, the predicted results may still need to be checked manually. This would be a time-consuming process because of the huge number of compounds. We hope that DAPredict can provide a convenient and valuable data resource for drug developers and pharmacogenomics researchers.</p>
  </sec>
</body>
<back>
  <sec sec-type="data-availability" id="s5">
    <title>Data availability</title>
    <p>All data in DAPredict are stored in the download section, and users can download it on demand.</p>
  </sec>
  <sec id="s6">
    <title>Contribution statement</title>
    <p>Conceptualization, Qingkang Meng and Xiujie Chen; Data curation, Yiyang Cai; Formal analysis, Qingkang Meng, Kun Zhou, Fei Xu and Diwei Huo; Funding acquisition, Xiujie Chen and Denan Zhang; Methodology, Qingkang Meng and Yiyang Cai; Project administration, Qingkang Meng and Xiujie Chen; Software, Kun Zhou, Fei Xu, Diwei Huo, Hongbo Xie, Meini Yu and Denan Zhang; Writing—original draft, Qingkang Meng; Writing—review and editing, Yiyang Cai, Kun Zhou, Fei Xu, Diwei Huo, Hongbo Xie, Meini Yu, Denan Zhang and Xiujie Chen.</p>
  </sec>
  <sec id="s7">
    <title>Funding</title>
    <p>Funding for open access charge: National Human Genome Research Institute (2P41HG02273-07). National Natural Science Foundation of China (Grant Number: 61671191, 62072144).</p>
  </sec>
  <sec sec-type="COI-statement" id="s8">
    <title>Conflict of interest statement</title>
    <p>None declared.</p>
  </sec>
  <sec id="s9">
    <title>Code availability</title>
    <p>No custom code was used. Software tools used for processing are mentioned in the Methods section.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berg</surname><given-names>E.L.</given-names></string-name></person-group> (<year>2021</year>) <article-title>The future of phenotypic drug discovery</article-title>. <source><italic toggle="yes">Cell Chem. Biol.</italic></source>, <volume>28</volume>, <fpage>424</fpage>–<lpage>430</lpage>.<pub-id pub-id-type="pmid">33529582</pub-id>
</mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luo</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2021</year>) <article-title>Biomedical data and computational models for drug repositioning: a comprehensive review</article-title>. <source><italic toggle="yes">Brief. Bioinformatics</italic></source>, <volume>22</volume>, <fpage>1604</fpage>–<lpage>1619</lpage>.<pub-id pub-id-type="pmid">32043521</pub-id>
</mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schcolnik-Cabrera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Juarez-Lopez</surname><given-names>D.</given-names></string-name> and <string-name><surname>Duenas-Gonzalez</surname><given-names>A.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Perspectives on drug repurposing</article-title>. <source><italic toggle="yes">Curr. Med. Chem.</italic></source>, <volume>28</volume>, <fpage>2085</fpage>–<lpage>2099</lpage>.<pub-id pub-id-type="pmid">32867630</pub-id>
</mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brogi</surname><given-names>S.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Computational approaches for drug discovery</article-title>. <source><italic toggle="yes">Molecules</italic></source>, <volume>24</volume>, <page-range>3061</page-range>.</mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2015</year>) <article-title>Predicting drug-target interactions via within-score and between-score</article-title>. <source><italic toggle="yes">BioMed Res. Int.</italic></source>, <volume>2015</volume>, <page-range>350983</page-range>.</mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tabei</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pauwels</surname><given-names>E.</given-names></string-name>, <string-name><surname>Stoven</surname><given-names>V.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2012</year>) <article-title>Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>, <volume>28</volume>, <fpage>i487</fpage>–<lpage>i494</lpage>.<pub-id pub-id-type="pmid">22962471</pub-id>
</mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>L.</given-names></string-name></person-group>  <etal>et al.</etal> (<year>2021</year>) <article-title>Computational drug repositioning based on the relationships between substructure-indication</article-title>. <source><italic toggle="yes">Brief. Bioinformatics</italic></source>, <volume>22</volume>, <page-range>bbaa348</page-range>.</mixed-citation>
    </ref>
  </ref-list>
</back>
